StockMacro
Company, fund or insider

Help

Menu

BioCardia

$0.79 -14% in 6 monthsMarket cap $11.9M

BCDA on XNAS, Health Care, BioCardia, Inc., job postings

Measures activity, not value. Not investment advice.

Short interest reached 864K shares, 8.0 times a year earlier, as the stock fell 39% over 12 months.

  • Bad1 delisting notice filed in the last 90 days
  • BadNet loss $7.7M over 12 months against cash of $2.2M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
21
Website
biocardia.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 23 Mar 2027 (an estimate: a year ago it reported on 24 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $1.8M.
Quarter to 31 Dec 2021: revenue $79K, net income -$3.5MQuarter to 31 Dec 2021: revenue $79K, net income -$3.5MQuarter to 31 Mar 2022: revenue $60K, net income -$3.3MQuarter to 31 Mar 2022: revenue $60K, net income -$3.3MQuarter to 30 Jun 2022: revenue $974K, net income -$2.5MQuarter to 30 Jun 2022: revenue $974K, net income -$2.5MQuarter to 30 Sep 2022: revenue $212K, net income -$3.1MQuarter to 30 Sep 2022: revenue $212K, net income -$3.1MQuarter to 31 Dec 2022: revenue $106K, net income -$3.0MQuarter to 31 Dec 2022: revenue $106K, net income -$3.0MQuarter to 31 Mar 2023: revenue $64K, net income -$3.5MQuarter to 31 Mar 2023: revenue $64K, net income -$3.5MQuarter to 30 Jun 2023: revenue $43K, net income -$3.4MQuarter to 30 Jun 2023: revenue $43K, net income -$3.4MQuarter to 30 Sep 2023: revenue $357K, net income -$2.6MQuarter to 30 Sep 2023: revenue $357K, net income -$2.6MQuarter to 31 Dec 2023: revenue $13K, net income -$2.1MQuarter to 31 Dec 2023: revenue $13K, net income -$2.1MQuarter to 31 Mar 2024: revenue $55K, net income -$2.3MQuarter to 31 Mar 2024: revenue $55K, net income -$2.3MQuarter to 30 Jun 2024: revenue $3K, net income -$1.6MQuarter to 30 Jun 2024: revenue $3K, net income -$1.6MQuarter to 30 Sep 2024: revenue $0, net income -$1.7MQuarter to 30 Sep 2024: revenue $0, net income -$1.7MQuarter to 31 Dec 2024: revenue –, net income -$2.3MQuarter to 31 Mar 2025: revenue $0, net income -$2.7MQuarter to 31 Mar 2025: revenue $0, net income -$2.7MQuarter to 30 Jun 2025: revenue $0, net income -$2.0MQuarter to 30 Jun 2025: revenue $0, net income -$2.0MQuarter to 30 Sep 2025: revenue $0, net income -$1.5MQuarter to 30 Sep 2025: revenue $0, net income -$1.5MQuarter to 31 Dec 2025: revenue $0, net income -$2.0MQuarter to 31 Dec 2025: revenue $0, net income -$2.0MQuarter to 31 Mar 2026: revenue –, net income -$2.3MQuarter to 30 Jun 2026: revenue –, net income -$1.6MQuarter to 30 Sep 2026: revenue –, net income -$1.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $3.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$1.8M
30 Jun 2026–-$1.6M
31 Mar 2026–-$2.3M
31 Dec 2025$0-$2.0M
30 Sep 2025$0-$1.5M
30 Jun 2025$0-$2.0M
31 Mar 2025$0-$2.7M
31 Dec 2024–-$2.3M
30 Sep 2024$0-$1.7M
30 Jun 2024$3K-$1.6M
31 Mar 2024$55K-$2.3M
31 Dec 2023$13K-$2.1M
30 Sep 2023$357K-$2.6M
30 Jun 2023$43K-$3.4M
31 Mar 2023$64K-$3.5M
31 Dec 2022$106K-$3.0M
30 Sep 2022$212K-$3.1M
30 Jun 2022$974K-$2.5M
31 Mar 2022$60K-$3.3M
31 Dec 2021$79K-$3.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$7.7M -$8.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -443% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $2.2M $5.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$2.2M (net cash) -$5.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.06
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 14.2 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
BioCardiaBCDA (this company) $11.9Mloss–––
BioStem TechnologiesBSEM $12.2M––––
Dyadic InternationalDYAI $11.5Mloss3.7-7.6%-227%
Passage BioPASG $12.6Mloss–––
Acumen PharmaceuticalsABOS $13.5Mloss–––
PluriPLUR $13.5Mloss9.3+10%–

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$4K

bought $4K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-4.8%

20 13F filers vs 21

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

9.3%

1.4M shares held by 13F filers (30 Sep 2026) of 15.1M outstanding (11 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.9%

735K shares sold short (30 Oct 2026) of 15.1M outstanding (11 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.3

735K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+8.4%

678K shares sold short in the report before, 735K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

67%

67% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 40%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

12

12 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

12×

12 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 864K, 8.0× a year earlier

Price $0.79 on 20 Nov 2026, -39% over 12 months (12-month range $0.77 to $1.47)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $170K in the last 12 months (the 12 months before: $2.0M).
Revenue per quarter. Revenue $0 in the latest quarter.
Capital spending per quarter. Capital spending $1K in the latest quarter.
Institutional holders (13F filers). 20 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
20 Nov 20268-K and other filingsNasdaq notice: stockholders' equity of $835,000 below $2.5M minimum; plan to regain compliance due Jan 4, 2027
17 Nov 2026Sharp changeShort interest spike: short interest spike, 735K vs usual 241K (2026-10-30); 3.5x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 678K vs usual 241K (2026-10-15); 2.2x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 619K vs usual 235K (2026-09-30); 3.1x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 864K vs usual 226K (2026-09-15); 8.0x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 1.0M vs usual 217K (2026-08-31); 4.8x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 1.0M vs usual 217K (2026-08-14); 2.8x the same period a year earlier
21 Aug 20268-K and other filingsDelisting notice or listing transfer
18 Aug 2026Sharp changeShort interest spike: short interest spike, 1.1M vs usual 213K (2026-07-31); 12.5x the same period a year earlier
12 Jun 20268-K and other filingsDelisting notice or listing transfer
15 Apr 20268-K and other filingsDelisting notice or listing transfer
3 Dec 20258-K and other filingsDirector or officer change
3 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Sep 20258-K and other filingsDelisting notice or listing transfer
17 Sep 20258-K and other filingsRegistered new securities for sale (S-1)
16 Sep 20258-K and other filingsRegistered new securities for sale (S-1)
26 Apr 2025Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 11 filing(s) in 30 days, value_usd total 561K)
4 Apr 20258-K and other filingsDelisting notice or listing transfer
17 Sep 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 174K (2024-08-30); 9.2x the same period a year earlier
29 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
9 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
16 Apr 2024Sharp changeShort interest spike: short interest spike, 536K vs usual 178K (2024-03-28); 19.6x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 1.0M vs usual 166K (2024-03-15); 27.0x the same period a year earlier
12 Mar 20248-K and other filingsDelisting notice or listing transfer
15 Sep 20238-K and other filingsDelisting notice or listing transfer
12 Sep 20238-K and other filingsDelisting notice or listing transfer
30 Jun 20238-K and other filingsA major agreement ended
3 May 2022Sharp changeShort interest spike: short interest spike, 1.2M vs usual 314K (2022-04-14); 3.0x the same period a year earlier
1 Mar 2022Sharp changeShort interest spike: short interest spike, 1.1M vs usual 283K (2022-02-15); 5.0x the same period a year earlier
Insider net buying (open market)
Month from 1 Apr 2022: $19K published
Month from 1 May 2022: $27K published
Month from 1 Jun 2022: $7K published
Month from 1 Sep 2022: $14K published
Month from 1 Oct 2022: $4K published
Month from 1 Nov 2022: $8K published
Month from 1 Dec 2022: $1.0M published
Month from 1 Apr 2023: $187 published
Month from 1 May 2023: $10K published
Month from 1 Jan 2024: -$56K published
Month from 1 Feb 2024: $50K published
Month from 1 Mar 2024: $195 published
Month from 1 Apr 2024: $1K published
Month from 1 Jun 2024: $7K published
Month from 1 Jul 2024: $2K published
Month from 1 Nov 2024: $3K published
Month from 1 Dec 2024: -$4K published
Month from 1 Jan 2025: $2K published
Month from 1 Feb 2025: $1K published
Month from 1 Mar 2025: $92K published
Month from 1 Apr 2025: $586K published
Month from 1 May 2025: $6K published
Month from 1 Jul 2025: $361K published
Month from 1 Aug 2025: $5K published
Month from 1 Sep 2025: $918K published
Month from 1 Dec 2025: $1K published
Month from 1 Jan 2026: $1K published
Month from 1 Feb 2026: $6K published
Month from 1 Mar 2026: $1K published
Month from 1 Apr 2026: $7K published
Month from 1 May 2026: $12K published
Month from 1 Jun 2026: $110K published
Month from 1 Jul 2026: $20K published
Month from 1 Aug 2026: $7K published
Month from 1 Sep 2026: $3K published
Month from 1 Oct 2026: $2K published
Revenue per quarter
Quarter ended 31 Dec 2021: $79K, +72% on a year earlier; public on 30 Mar 2022
Quarter ended 31 Mar 2022: $60K, +30% on a year earlier; public on 12 May 2022
Quarter ended 30 Jun 2022: $974K, +1312% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $212K, -74% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $106K, +34% on a year earlier; public on 30 Mar 2023
Quarter ended 31 Mar 2023: $64K, +6.7% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $43K, -96% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $357K, +68% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $13K, -88% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $55K, -14% on a year earlier; public on 15 May 2024
Quarter ended 30 Jun 2024: $3K, -93% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Mar 2025: $0, -100% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $0, -100% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $0; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $0; public on 25 Mar 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $41K; public on 30 Mar 2022
Quarter ended 31 Mar 2022: $29K, +7.4% on a year earlier; public on 12 May 2022
Quarter ended 30 Jun 2022: $25K, -11% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $14K, -30% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $2K, -95% on a year earlier; public on 30 Mar 2023
Quarter ended 31 Mar 2023: $10K, -66% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $2K, -92% on a year earlier; public on 10 Aug 2023
Quarter ended 31 Mar 2024: $0, -100% on a year earlier; public on 15 May 2024
Quarter ended 30 Jun 2024: $3K, +50% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $2K; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $1K; public on 27 Mar 2025
Quarter ended 31 Mar 2025: $0; public on 16 May 2026
Quarter ended 30 Jun 2025: $1K, -67% on a year earlier; public on 12 Aug 2025
Quarter ended 31 Dec 2025: $6K, +500% on a year earlier; public on 25 Mar 2026
Quarter ended 31 Mar 2026: $3K; public on 16 May 2026
Quarter ended 30 Sep 2026: $1K; public on 13 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 23; public on 14 Feb 2022
31 Mar 2022 report: 23; public on 16 May 2022
30 Jun 2022 report: 24; public on 15 Aug 2022
30 Sep 2022 report: 22; public on 14 Nov 2022
31 Dec 2022 report: 24; public on 14 Feb 2023
31 Mar 2023 report: 22; public on 15 May 2023
30 Jun 2023 report: 22; public on 14 Aug 2023
30 Sep 2023 report: 19; public on 14 Nov 2023
31 Dec 2023 report: 23; public on 14 Feb 2024
31 Mar 2024 report: 21; public on 15 May 2024
30 Jun 2024 report: 9; public on 14 Aug 2024
30 Sep 2024 report: 9; public on 14 Nov 2024
31 Dec 2024 report: 13; public on 14 Feb 2025
31 Mar 2025 report: 12; public on 15 May 2025
30 Jun 2025 report: 15; public on 14 Aug 2025
30 Sep 2025 report: 18; public on 14 Nov 2025
31 Dec 2025 report: 20; public on 17 Feb 2026
31 Mar 2026 report: 18; public on 15 May 2026
30 Jun 2026 report: 21; public on 14 Aug 2026
30 Sep 2026 report: 20; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 864K shares sold short in the 15 Sep 2026 report, 8.0× the same report last year; it also had 1.0M shares sold short in the 31 Aug 2026 report, 4.8× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 864K shares sold short in the 15 Sep 2026 report, 8.0× the same report last year Public on 25 Sep 2026.
  • Insider net buying (open market): Insiders bought a net $170K in the last 12 months (the 12 months before: $2.0M).
  • Revenue per quarter: Revenue $0 in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: no sales; 4 purchases, $4K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Oct 2026Peter AltmanPresident and CEOBuy500$0.95$475Form 4
30 Sep 2026Peter AltmanPresident and CEOBuy1,000$1.03$1KForm 4
23 Sep 2026Peter AltmanPresident and CEOBuy1,900$1.05$2KForm 4
4 Sep 2026Peter AltmanPresident and CEOBuy800$1.09$872Form 4
18 Aug 2026Peter AltmanPresident and CEOBuy5,400$0.93$5KForm 4
13 Aug 2026Peter AltmanPresident and CEOBuy1,900$0.92$2KForm 4
29 Jul 2026Peter AltmanPresident and CEOBuy5,000$0.78$4KForm 4
20 Jul 2026Peter AltmanPresident and CEOBuy500$0.83$415Form 4

20 institutions reported shares at the end of Q3 2026, 9% of the shares outstanding; 1 opened a position, 1 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
CM Management, LLC400K2.64%$404K+100K+33%
Citigroup Inc275K1.82%$278K-123K-31%
Pingora Partners LLC160K1.05%$161K+39K+33%
Vanguard Capital Management LLC125K0.82%$126KNo change
Geode Capital Management, LLC105K0.69%$106K+38K+57%
Vanguard Fiduciary Trust Co66K0.44%$67KNo change
Gsa Capital Partners LLP55K0.36%+42K+326%
Brown Advisory Inc49K0.32%$49K+13K+37%
HRT Financial LP45K0.30%New+45K
Susquehanna International Group, LLP39K0.26%$39K+80%

Company events

All 55 company events

In 12 months: 4 delisting notices, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
20 Nov 2026Nasdaq notice: stockholders' equity of $835,000 below $2.5M minimum; plan to regain compliance due Jan 4, 20278-K
21 Aug 2026Delisting notice or listing transfer8-K
12 Jun 2026Delisting notice or listing transfer8-K
15 Apr 2026Delisting notice or listing transfer8-K
3 Dec 2025Director or officer changeSame filing: shareholder vote results8-K
24 Sep 2025Delisting notice or listing transfer8-K
17 Sep 2025Registered new securities for sale (S-1)S-1/A
16 Sep 2025Registered new securities for sale (S-1)S-1

The 5 newest of 53 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 20 Nov 2026Filings record

    Nasdaq notice: stockholders' equity of $835,000 below $2.5M minimum; plan to regain compliance due Jan 4, 2027

  2. 11 Nov 2026Short interest and volume change

    had 735K shares sold short in the 30 Oct 2026 report, 3.5× the same report last year.

    Same report last year: 211K; its normal report is 241K.

    See the evidence
    This period
    735K (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    241K
    Typical spread (median absolute deviation)
    70K
    How far from its usual level
    +4.8
    Same report last year
    211K
    History used
    3,227 days
    2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M2026-08-31: 1.0M2026-09-15: 864K2026-09-30: 619K2026-10-15: 678K2026-10-30: 735K
    the 30 Oct 2026 report24 earlier reportsnormal: 241K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 27 Oct 2026Short interest and volume change

    had 678K shares sold short in the 15 Oct 2026 report, 2.2× the same report last year.

    Same report last year: 306K; its normal report is 241K.

    See the evidence
    This period
    678K (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    241K
    Typical spread (median absolute deviation)
    66K
    How far from its usual level
    +4.5
    Same report last year
    306K
    History used
    3,212 days
    2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M2026-08-31: 1.0M2026-09-15: 864K2026-09-30: 619K2026-10-15: 678K
    the 15 Oct 2026 report24 earlier reportsnormal: 241K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 20 Oct 2026Insiders record

    Altman Peter (President and CEO) bought 500 shares of BCDA ($475)

  5. 10 Oct 2026Short interest and volume change

    had 619K shares sold short in the 30 Sep 2026 report, 3.1× the same report last year.

    Same report last year: 199K; its normal report is 235K.

    See the evidence
    This period
    619K (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    235K
    Typical spread (median absolute deviation)
    59K
    How far from its usual level
    +4.4
    Same report last year
    199K
    History used
    3,197 days
    2025-09-30: 199K2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M2026-08-31: 1.0M2026-09-15: 864K2026-09-30: 619K
    the 30 Sep 2026 report24 earlier reportsnormal: 235K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 1 Oct 2026Insiders record

    Altman Peter (President and CEO) bought 1,000 shares of BCDA ($1,030) (dated 30 Sep 2026)

  7. 25 Sep 2026Short interest and volume change

    had 864K shares sold short in the 15 Sep 2026 report, 8.0× the same report last year.

    Same report last year: 107K; its normal report is 226K.

    See the evidence
    This period
    864K (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    226K
    Typical spread (median absolute deviation)
    50K
    How far from its usual level
    +8.6
    Same report last year
    107K
    History used
    3,182 days
    2025-09-15: 107K2025-09-30: 199K2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M2026-08-31: 1.0M2026-09-15: 864K
    the 15 Sep 2026 report24 earlier reportsnormal: 226K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 24 Sep 2026Insiders record

    Altman Peter (President and CEO) bought 1,900 shares of BCDA ($1,995) (dated 23 Sep 2026)

  9. 11 Sep 2026Short interest and volume change

    had 1.0M shares sold short in the 31 Aug 2026 report, 4.8× the same report last year.

    Same report last year: 209K; its normal report is 217K.

    See the evidence
    This period
    1.0M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    217K
    Typical spread (median absolute deviation)
    40K
    How far from its usual level
    +13.3
    Same report last year
    209K
    History used
    3,167 days
    2025-08-29: 209K2025-09-15: 107K2025-09-30: 199K2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M2026-08-31: 1.0M
    the 31 Aug 2026 report24 earlier reportsnormal: 217K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 5 Sep 2026Insiders record

    Altman Peter (President and CEO) bought 800 shares of BCDA ($872) (dated 4 Sep 2026)

  11. 26 Aug 2026Short interest and volume change

    had 1.0M shares sold short in the 14 Aug 2026 report, 2.8× the same report last year.

    Same report last year: 373K; its normal report is 217K.

    See the evidence
    This period
    1.0M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    217K
    Typical spread (median absolute deviation)
    40K
    How far from its usual level
    +13.7
    Same report last year
    373K
    History used
    3,150 days
    2025-08-15: 373K2025-08-29: 209K2025-09-15: 107K2025-09-30: 199K2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M2026-08-14: 1.0M
    the 14 Aug 2026 report24 earlier reportsnormal: 217K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 21 Aug 2026Filings record

    Delisting notice or listing transfer

  13. 19 Aug 2026Insiders record

    Altman Peter (President and CEO) bought 5,400 shares of BCDA ($5,022) (dated 18 Aug 2026)

  14. 14 Aug 2026Insiders record

    Altman Peter (President and CEO) bought 1,900 shares of BCDA ($1,748) (dated 13 Aug 2026)

  15. 12 Aug 2026Short interest and volume change

    had 1.1M shares sold short in the 31 Jul 2026 report, 12× the same report last year.

    Same report last year: 89K; its normal report is 213K.

    See the evidence
    This period
    1.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    213K
    Typical spread (median absolute deviation)
    36K
    How far from its usual level
    +16.5
    Same report last year
    89K
    History used
    3,136 days
    2025-07-31: 89K2025-08-15: 373K2025-08-29: 209K2025-09-15: 107K2025-09-30: 199K2025-10-15: 306K2025-10-31: 211K2025-11-14: 175K2025-11-28: 185K2025-12-15: 167K2025-12-31: 249K2026-01-15: 216K2026-01-30: 233K2026-02-13: 236K2026-02-27: 218K2026-03-13: 192K2026-03-31: 177K2026-04-15: 177K2026-04-30: 166K2026-05-15: 246K2026-05-29: 329K2026-06-15: 439K2026-06-30: 372K2026-07-15: 1.3M2026-07-31: 1.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 213K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 30 Jul 2026Insiders record

    Altman Peter (President and CEO) bought 5,000 shares of BCDA ($3,900) (dated 29 Jul 2026)

  17. 21 Jul 2026Insiders record

    Altman Peter (President and CEO) bought 500 shares of BCDA ($415) (dated 20 Jul 2026)

  18. 16 Jul 2026Insiders record

    Altman Peter (President and CEO) bought 4,300 shares of BCDA ($3,754) (dated 15 Jul 2026)

  19. 11 Jul 2026Insiders record

    Altman Peter (President and CEO) bought 7,500 shares of BCDA ($7,175) (dated 10 Jul 2026)

  20. 9 Jul 2026Insiders record

    Altman Peter (President and CEO) bought 5,400 shares of BCDA ($5,184) (dated 8 Jul 2026)

  21. 25 Jun 2026Insiders record

    STERTZER SIMON H (director) bought 109,200 shares of BCDA ($103,584) (dated 24 Jun 2026)

  22. 23 Jun 2026Insiders record

    Altman Peter (President and CEO) bought 2,300 shares of BCDA ($2,043) (dated 22 Jun 2026)

  23. 12 Jun 2026Filings record

    Delisting notice or listing transfer

  24. 10 Jun 2026Insiders record

    Altman Peter (President and CEO) bought 5,000 shares of BCDA ($4,250) (dated 9 Jun 2026)

  25. 22 May 2026Insiders record

    Altman Peter (President and CEO) bought 1,700 shares of BCDA ($1,570) (dated 21 May 2026)

  26. 19 May 2026Insiders record

    Altman Peter (President and CEO) bought 5,700 shares of BCDA ($5,244) (dated 18 May 2026)

  27. 16 May 2026Insiders record

    Altman Peter (President and CEO) bought 5,100 shares of BCDA ($5,202) (dated 15 May 2026)

  28. 30 Apr 2026Insiders record

    Altman Peter (President and CEO) bought 5,000 shares of BCDA ($5,550) (dated 29 Apr 2026)

  29. 23 Apr 2026Insiders record

    Altman Peter (President and CEO) bought 1,000 shares of BCDA ($1,230) (dated 22 Apr 2026)

  30. 15 Apr 2026Filings record

    Delisting notice or listing transfer

  31. 27 Mar 2026Insiders record

    Altman Peter (President and CEO) bought 900 shares of BCDA ($1,110) (dated 26 Mar 2026)

  32. 5 Feb 2026Insiders record

    Altman Peter (President and CEO) bought 5,000 shares of BCDA ($5,650) (dated 4 Feb 2026)

  33. 22 Jan 2026Insiders record

    Altman Peter (President and CEO) bought 900 shares of BCDA ($1,194) (dated 21 Jan 2026)

  34. 18 Dec 2025Insiders record

    Altman Peter (President and CEO) bought 1,100 shares of BCDA ($1,444) (dated 17 Dec 2025)

  35. 3 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 3 Dec 2025Filings record

    Director or officer change

  37. 24 Sep 2025Filings record

    Delisting notice or listing transfer

  38. 24 Sep 2025Insiders record

    Altman Peter (President and CEO) bought 48,000 shares of BCDA ($60,000) (dated 23 Sep 2025)

  39. 24 Sep 2025Insiders record

    Blank Andrew Scott (director) bought 288,000 shares of BCDA ($360,000) (dated 23 Sep 2025)

  40. 24 Sep 2025Insiders record

    STERTZER SIMON H (director) bought 398,400 shares of BCDA ($498,000) (dated 23 Sep 2025)

Showing the newest 40 of 141 entries; narrow the window or the kind of data to see older ones.

Not listed: 188 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000925741
Ticker
BCDA
Domain
biocardia.com
Hq location
CA|SUNNYVALE|94085 (1 unverified)
Name
BioCardia, Inc., BioCardia Lifesciences, Inc, Cardo Medical, Inc., CLICKNSETTLE COM INC and 4 more
Uei
V2H1YT1UP8V5
  • SEC Form 13F institutional holdings360 data points31 Dec 2016 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)221 records25 Mar 2016 to 20 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)931 data points31 Dec 2009 to 11 Nov 2026
  • SEC Form 4 insider transactions156 records, 488 data points24 Mar 2016 to 20 Oct 2026
  • FINRA short interest (twice monthly)626 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3646 data points2 Aug 2019 to 20 Nov 2026
  • USASpending.gov federal awards33 data points27 Feb 2008 to 24 Jan 2014